Thrivent Financial for Lutherans’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$923K Sell
12,000
-7,181
-37% -$560K ﹤0.01% 1932
2025
Q4
$1.51M Sell
19,181
-38,846
-67% -$3.36M ﹤0.01% 1659
2025
Q3
$5.32M Buy
58,027
+45,516
+364% +$3.71M 0.01% 833
2025
Q2
$816K Buy
12,511
+321
+3% +$20.9K ﹤0.01% 1908
2025
Q1
$816K Sell
12,190
-638
-5% -$38.1K ﹤0.01% 1842
2024
Q4
$709K Sell
12,828
-200
-2% -$11.5K ﹤0.01% 2087
2024
Q3
$777K Buy
13,028
+299
+2% +$18.2K ﹤0.01% 2054
2024
Q2
$811K Sell
12,729
-349
-3% -$22.7K ﹤0.01% 1981
2024
Q1
$904K Sell
13,078
-356
-3% -$21.5K ﹤0.01% 1949
2023
Q4
$741K Sell
13,434
-1,223
-8% -$67.3K ﹤0.01% 2027
2023
Q3
$851K Buy
14,657
+1,337
+10% +$77.2K ﹤0.01% 1845
2023
Q2
$717K Buy
13,320
+1,212
+10% +$53.7K ﹤0.01% 2013
2023
Q1
$481K Sell
12,108
-424
-3% -$17.9K ﹤0.01% 2148
2022
Q4
$504K Buy
12,532
+60
+0.5% +$2.25K ﹤0.01% 2114
2022
Q3
$401K Sell
12,472
-397
-3% -$13.6K ﹤0.01% 2152
2022
Q2
$382K Buy
12,869
+2,511
+24% +$72.4K ﹤0.01% 2191
2022
Q1
$291K Buy
10,358
+1,550
+18% +$57.8K ﹤0.01% 2351
2021
Q4
$406K Buy
8,808
+974
+12% +$41.9K ﹤0.01% 2252
2021
Q3
$257K Sell
7,834
-283
-3% -$8.8K ﹤0.01% 2375
2021
Q2
$284K Buy
8,117
+205
+3% +$6.97K ﹤0.01% 2346
2021
Q1
$286K Sell
7,912
-1,493
-16% -$46.7K ﹤0.01% 2399
2020
Q4
$273K Buy
9,405
+1,458
+18% +$41.8K ﹤0.01% 2335
2020
Q3
$224K Hold
7,947
﹤0.01% 2264
2020
Q2
$257K Buy
7,947
+151
+2% +$5.41K ﹤0.01% 2155
2020
Q1
$318K Buy
7,796
+390
+5% +$20.7K ﹤0.01% 1952
2019
Q4
$457K Buy
7,406
+19
+0.3% +$1.26K ﹤0.01% 1931
2019
Q3
$538K Buy
7,387
+879
+14% +$65.8K ﹤0.01% 1796
2019
Q2
$535K Buy
6,508
+182
+3% +$12.9K ﹤0.01% 1793
2019
Q1
$446K Buy
6,326
+475
+8% +$27.9K ﹤0.01% 1853
2018
Q4
$263K Sell
5,851
-500
-8% -$26.2K ﹤0.01% 1847
2018
Q3
$359K Buy
6,351
+125
+2% +$7.65K ﹤0.01% 1821
2018
Q2
$416K Buy
6,226
+429
+7% +$26.8K ﹤0.01% 1771
2018
Q1
$338K Buy
5,797
+186
+3% +$11.8K ﹤0.01% 1820
2017
Q4
$362K Buy
5,611
+111
+2% +$6.91K ﹤0.01% 1833
2017
Q3
$289K Buy
5,500
+660
+14% +$31.5K ﹤0.01% 1800
2017
Q2
$227K Buy
4,840
+320
+7% +$15.4K ﹤0.01% 1831
2017
Q1
$224K Buy
4,520
+220
+5% +$12.4K ﹤0.01% 1814
2016
Q4
$261K Buy
4,300
+240
+6% +$14.7K ﹤0.01% 1766
2016
Q3
$269K Buy
4,060
+400
+11% +$25K ﹤0.01% 1746
2016
Q2
$204K Buy
+3,660
New +$178K ﹤0.01% 1790

Other funds holding ANIP